Feedback
AJANTPHARM 
Reputation: 642,897 • May 11, 2022 1:41 AM
Ajanta Pharma Q4 Results: Net profit falls 5% to Rs 151 cr
For the year ended March 31, 2022, the company posted a PAT of Rs 713 crore. It was Rs 654 crore in FY21. Revenue from operations rose to Rs 3,341 crore last fiscal as against Rs 2,890 crore in 2020-21.
The Economic Times
Vote
Comment
Share
NSE:AJANTPHARM price when posted: 1,658.1